RhumbLine Advisers’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$33.7K Sell
2024
Q4
$107K Sell
2024
Q3
$124K Buy
2024
Q2
$94K Buy
2024
Q1
$77.8K Buy
2023
Q4
$45.6K Sell
2023
Q3
$90.6K Buy
2023
Q2
$116K Buy